ReviewCancer cell international2022

Clinical potential of PD-1/PD-L1 blockade therapy for renal cell carcinoma (RCC): a rapidly evolving strategy.

Mohammadsaleh Jahangir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.